Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2003
03/05/2003EP1287112A2 Preparing a sample to be analysed from a sample with very large volume
03/05/2003EP1287032A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
03/05/2003EP1287031A2 Polynucleotides encoding for polymorphic isoforms of the pthrp protein, the encoded proteins and their therapeutic applications thereof
03/05/2003EP1287030A1 Insulin regulated substance (irs-2) induced by pioglitazone, assay and use thereof
03/05/2003EP1287028A2 Compositions and methods for the therapy and diagnosis of colon cancer
03/05/2003EP1287025A1 Sheep lice, bovicola ovis, allergen treatment
03/05/2003EP1287024A2 Virulence genes, proteins, and their use
03/05/2003EP1287022A2 Human ion channels
03/05/2003EP1287020A2 Cancer diagnosis and assays for screening anti-cancer agents
03/05/2003EP1287019A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
03/05/2003EP1287015A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
03/05/2003EP1287012A1 Nucleotide analogues comprising a reporter moiety and a polymerase enzyme blocking moiety
03/05/2003EP1286913A2 Microfluidic concentration gradient loop
03/05/2003EP1286698A1 Methods for reducing tumor growth and metastasis by inhibiting mcp-1 activity
03/05/2003EP1286697A2 Method for selectively inhibiting ghrelin action
03/05/2003EP1286682A1 Methods and compositions for inhibiting immunoglobulin-mediated--reperfusion injury
03/05/2003EP1246678A4 Physiological fluid separation vehicles having improved resistance to inward migration of therapeutic agents
03/05/2003EP1230387A4 Assays for short sequence variants
03/05/2003EP1221051A4 Resonant optical cavities for high-sensitivity, high-throughput biological sensors and methods
03/05/2003EP1159459A4 A detectable cationic flocculant and method of using same in industrial food processes
03/05/2003EP1090073B1 Xanthene dyes and their application as luminescence quenching compounds
03/05/2003EP1069907A4 DIAGNOSIS, PREVENTION AND TREATMENT OF ULCERATIVE COLITIS, AND CLINICAL SUBTYPES THEREOF, USING MICROBIAL UC pANCA ANTIGENS
03/05/2003EP1009850B1 Low volume electrochemical sensor
03/05/2003EP0988533B1 Biosensor comprising a lipid membrane containing gated ion channels
03/05/2003EP0912757A4 Solid-phase activity assay for biologically active substance
03/05/2003EP0877795A4 Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use
03/05/2003EP0874851B1 Macrocyclic compounds made from carbon suboxide units
03/05/2003EP0845034B1 peptide having pronociceptive properties
03/05/2003EP0728143B1 Oncoprotein protein kinase
03/05/2003EP0669913B1 Detection of hypoxia
03/05/2003EP0625157B1 PLATELET GPIIIa P1A1 AND P1A2 EPITOPES, THEIR PREPARATION AND USE
03/05/2003EP0602126B1 Immunoglobulin variants for specific fc epsilon receptors
03/05/2003CN2539181Y Portable water quantity tester
03/05/2003CN1401079A Process for the identification of IGG-producing cells and no IGG-producing cells
03/05/2003CN1401078A Specific bonding analysis method and specific bonding analysis device using it
03/05/2003CN1401077A Method for examination of feces ocoult blood
03/05/2003CN1401076A Analytical element, and measuring instrument and substrate determining method using the same
03/05/2003CN1401074A 过滤装置 Filtration device
03/05/2003CN1401071A Device for measuring mass flow and energy content
03/05/2003CN1401001A 5HT3 receptors of nematodes, polynucleotide molecules encoding same, and antagonists thereof
03/05/2003CN1401000A Method of detecting ligand or ligand-like low-molecular weight compound
03/05/2003CN1400467A Fluorescence rare earth complex silicone nano granules labeling compound and its preparation method
03/05/2003CN1400466A Pisposable biological sensor with spacer layer and its production method
03/05/2003CN1400465A Predetermination method of bendability and shearing property of spun fabric
03/05/2003CN1400462A Equipment and method for determing the physical and chemical change in biological sample
03/05/2003CN1400459A On-line COD water quality testing method
03/05/2003CN1400457A Room temperature solidification storage method of antibody
03/05/2003CN1400316A Collapsin reaction medium protein-1
03/05/2003CN1400222A Monoclonal antibody resisting human small cell lung carcinoma and its application
03/05/2003CN1102735C Capillary electrophoretic glue-free sieving system for gene diagnosis
03/05/2003CN1102598C Peptides derived from human heat shock protein 60, compositions and application thereof
03/05/2003CN1102594C Agent for suppressing interferencein immuno assaying
03/05/2003CA2398348A1 Devices for analyte concentration determination and methods of using the same
03/05/2003CA2398077A1 Devices for analyte concentration determination and methods of manufacturing and using the same
03/04/2003WO2004019024A1 Base sequencing electrode, base sequencing device, and base sequencing method
03/04/2003US6529835 High throughput methods, systems and apparatus for performing cell based screening assays
03/04/2003US6529269 Paper sheet identification method and device
03/04/2003US6529016 Apparatus monitoring the deposition of a liquid-to-pasty medium on a substrate
03/04/2003US6528802 Method for optical excitation of fluorophore marked DNA and RNA
03/04/2003US6528656 Linear or cyclic aminophosphonates as pH markers in phosphorus 31 NMR spectroscopy
03/04/2003US6528648 Detecting reagent for double-stranded nucleic acid and double-stranded nucleic acid detecting method
03/04/2003US6528641 Methods and reagents for preserving RNA in cell and tissue samples
03/04/2003US6528634 Aiolos gene
03/04/2003US6528626 Viral library for use in the diagnosis and treatment of viral diseases
03/04/2003US6528623 Antibodies that specifically bind ACT-4-L-h-1 ligand
03/04/2003US6528485 Human growth hormone releasing factor-PEG conjugates; PEG unit is covalently bound to the amino group of Lys21 of SEQ ID NO:1; the hGRF-PEG conjugate does not contain a triazine group
03/04/2003US6528482 Receptor activator of NF-κB
03/04/2003US6528325 Method for the visual detection of specific antibodies in human serum by the use of lateral flow assays
03/04/2003US6528323 Bidirectional lateral flow test strip and method
03/04/2003US6528322 Analytical method and apparatus
03/04/2003US6528321 Opposable-element chromatographic assay device for detection of analytes in whole blood samples
03/04/2003US6528320 Method and apparatus for desorption and ionization of analytes
03/04/2003US6528317 Method of providing a detectable marker in a fluid
03/04/2003US6528310 Cancer control
03/04/2003US6528303 Neuropeptide Y-Y5 receptor
03/04/2003US6528302 Thin-well microplate and methods of making same
03/04/2003US6528299 Inhibited by aprotinin; increased activity by calcium ions and/or heparin or related substances; proenzyme; use in therapy or prophylaxis of bleeding events, wound healing, disorders caused by fibrin-containing thrombin
03/04/2003US6528291 Slide with plasma polymerized layer derived from a hexamethyl disiloxane or disilazane, and a plasma polymerized layer derived from acrolein or benzaldehyde, and an immobilized monolayer of a biomolecule; microarrays
03/04/2003US6528284 S-Region Transfer Activity-70 (SRTA-70); can be used as therapeutic agents in immune response modulation
03/04/2003US6528281 DNA encoding human interleukin-11 receptor
03/04/2003US6528279 Method and apparatus for analyzing three-dimensional internal structure
03/04/2003US6528278 Diagnosing urogenital cancers; obtain urogenital cells, incubate with dye, expose to preferential light source, monitor light scattering pattern compare to control
03/04/2003US6528275 Substrates and inhibitors of proteolytic enzymes
03/04/2003US6528273 Coagulation control comprising an abnormal plasma, and an anticoagulant having activity for enhancing the activity of antithrombin III or of heparin co-factor II against thrombin or against clotting factor IXa, Xa, or XIa; stability
03/04/2003US6528272 Applying a glycosphingolipid to a polyvinylidene fluoride surface, glycosphingolipid is a receptor, specifically binds the component, applying test sample, incubating the surface with an antibody which specifically binds to the component
03/04/2003US6528271 Drug screening
03/04/2003US6528270 Methods for identifying compounds for treatment of cell proliferative disorders associated with adaptor protein interactions
03/04/2003US6528269 Monoclonal antibodies; can be used to diagnose neurodegenerative disorders
03/04/2003US6528263 Identifying a cell expressing protooncogene polypeptide by contacting a nucleic acid with a polynucleotide reagent and detecting its binding; can be used in diagnosis and treatment of cancer
03/04/2003US6528252 Methods for identifying a protease inhibitor
03/04/2003US6528251 Transfecting a cell line susceptible to infection by HIV with a sequence from the pol gene of HIV, which sequence encodes a desired target enzyme
03/04/2003US6528247 Activation of apoptin-induced apoptosis by large T-Antigen of SV40 in normal and cancer-prone cells; can be used in diagnosis and treatment of cancer
03/04/2003US6528165 Encapsulation of discrete quanta of fluorescent particles
03/04/2003US6528061 purified immunogenic polypeptide comprising a polysaccharide mimotope recognized by a protective monoclonal antibody having a specificity for a surface polysaccharide of a bacterium of the Shigella species, said surface polysaccharide
03/04/2003US6528059 Specific epitopic regions of thyroid peroxidase (TPO), a thyroid specific membrane autoantigen, have been identified within amino acid residues protein (SEQ ID NO:2), with at least one distinct binding region within TPO located from
03/04/2003US6528056 Inhibition of viral infection using antigen-binding proteins
03/04/2003US6528055 Polypeptide for use in the diagnosis, treatment and prevention of infections, immune response defects and autoimmune diseases
03/04/2003US6528039 Low density microspheres and their use as contrast agents for computed tomography and in other applications
03/04/2003US6528038 An immune response directed against Porphyromonas gingivalis. The composition includes a suitable adjuvant and/or acceptable carrier and one substantially purified P. gingivalis immunogen. The immunogen is selected from the group consisting
03/04/2003US6528037 Method for determining whether a compound is an insulin receptor kinase activator